Cargando…

Antitarget, Anti-SARS-CoV-2 Leads, Drugs, and the Drug Discovery–Genetics Alliance Perspective

[Image: see text] The most advanced antiviral molecules addressing major SARS-CoV-2 targets (Main protease, Spike protein, and RNA polymerase), compared with proteins of other human pathogenic coronaviruses, may have a short-lasting clinical efficacy. Accumulating knowledge on the mechanisms underly...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pozzi, Cecilia, Vanet, Anne, Francesconi, Valeria, Tagliazucchi, Lorenzo, Tassone, Giusy, Venturelli, Alberto, Spyrakis, Francesca, Mazzorana, Marco, Costi, Maria P., Tonelli, Michele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2023
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10005815/ https://www.ncbi.nlm.nih.gov/pubmed/36857133 http://dx.doi.org/10.1021/acs.jmedchem.2c01229

Ejemplares similares

Evidence of Pyrimethamine and Cycloguanil Analogues as Dual Inhibitors of Trypanosoma brucei Pteridine Reductase and Dihydrofolate Reductase
por: Tassone, Giusy, et al.
Publicado: (2021)

Structural Basis of Parasitic HSP90 ATPase Inhibition by Small Molecules
por: Tassone, Giusy, et al.
Publicado: (2022)

Structural Bases for the Synergistic Inhibition of Human Thymidylate Synthase and Ovarian Cancer Cell Growth by Drug Combinations
por: Pozzi, Cecilia, et al.
Publicado: (2021)

Selectivity Challenges in Docking Screens for GPCR Targets and Antitargets
por: Weiss, Dahlia R., et al.
Publicado: (2018)

Structural Characterization of Human Heat Shock Protein 90 N-Terminal Domain and Its Variants K112R and K112A in Complex with a Potent 1,2,3-Triazole-Based Inhibitor
por: Tassone, Giusy, et al.
Publicado: (2022)

Structural Comparison of Enterococcus faecalis and Human Thymidylate Synthase Complexes with the Substrate dUMP and Its Analogue FdUMP Provides Hints about Enzyme Conformational Variabilities
por: Pozzi, Cecilia, et al.
Publicado: (2019)

Repurposing the Trypanosomatidic GSK Kinetobox for the Inhibition of Parasitic Pteridine and Dihydrofolate Reductases
por: Santucci, Matteo, et al.
Publicado: (2021)

K(V)11.1, Na(V)1.5, and Ca(V)1.2 Transporter Proteins as Antitarget for Drug Cardiotoxicity
por: Kowalska, Magdalena, et al.
Publicado: (2020)

In silico Exploration of Interactions Between Potential COVID-19 Antiviral Treatments and the Pore of the hERG Potassium Channel—A Drug Antitarget
por: Al-Moubarak, Ehab, et al.
Publicado: (2021)

Recovering Actives in Multi-Antitarget and Target Design of Analogs of the Myosin II Inhibitor Blebbistatin
por: Roman, Bart I., et al.
Publicado: (2018)

Antitarget Interaction, Acute Toxicity and Protein Binding Studies of Quinazolinedione Sulphonamides as GABA(1) Antagonists
por: Ajeet,, et al.
Publicado: (2016)

Targeting Methyltransferases in Human Pathogenic Bacteria: Insights into Thymidylate Synthase (TS) and Flavin-Dependent TS (FDTS)
por: Pozzi, Cecilia, et al.
Publicado: (2019)

Validation of Recombinant Chicken Liver Bile Acid Binding Protein as a Tool for Cholic Acid Hosting
por: Tassone, Giusy, et al.
Publicado: (2021)

Dynamic Interplay between Copper Toxicity and Mitochondrial Dysfunction in Alzheimer’s Disease
por: Tassone, Giusy, et al.
Publicado: (2021)

Probing In Silico the Benzimidazole Privileged Scaffold for the Development of Drug-like Anti-RSV Agents
por: Cichero, Elena, et al.
Publicado: (2021)

Comparison of Quantitative and Qualitative (Q)SAR Models Created for the Prediction of K(i) and IC(50) Values of Antitarget Inhibitors
por: Lagunin, Alexey A., et al.
Publicado: (2018)

Accelerating Drug Discovery Efforts for Trypanosomatidic Infections Using an Integrated Transnational Academic Drug Discovery Platform
por: Moraes, Carolina B., et al.
Publicado: (2019)

Spirotetronate Polyketides as Leads in Drug Discovery
por: Lacoske, Michelle H., et al.
Publicado: (2014)

Fragment-Based Lead Discovery Strategies in Antimicrobial Drug Discovery
por: Konaklieva, Monika I., et al.
Publicado: (2023)

Designing Chimeric Molecules for Drug Discovery by Leveraging Chemical Biology
por: Borsari, Chiara, et al.
Publicado: (2020)

Natural Products as Leads in Schistosome Drug Discovery
por: Neves, Bruno J., et al.
Publicado: (2015)

Lead/Drug Discovery from Natural Resources
por: Xu, Zhihong, et al.
Publicado: (2022)

Synthesis, biological evaluation and molecular modeling of novel azaspiro dihydrotriazines as influenza virus inhibitors targeting the host factor dihydrofolate reductase (DHFR)
por: Francesconi, Valeria, et al.
Publicado: (2018)

Targeting Class A and C Serine β-Lactamases with a Broad-Spectrum Boronic Acid Derivative
por: Tondi, Donatella, et al.
Publicado: (2014)

Synthetic lethals in HIV: ways to avoid drug resistance: Running title: Preventing HIV resistance
por: Petitjean, Michel, et al.
Publicado: (2015)

Co-lethality studied as an asset against viral drug escape: the HIV protease case
por: Brouillet, Sophie, et al.
Publicado: (2010)

Alliance between the International Union of Basic and Clinical Pharmacology and the Indian Pharmacological Society for Health, Education, Drug Discovery, and Development in India
por: Spedding, Michael, et al.
Publicado: (2016)

Computational Discovery of Putative Leads for Drug Repositioning through Drug-Target Interaction Prediction
por: Coelho, Edgar D., et al.
Publicado: (2016)

Lycorine: A prospective natural lead for anticancer drug discovery
por: Roy, Mridul, et al.
Publicado: (2018)

In silico Strategies to Support Fragment-to-Lead Optimization in Drug Discovery
por: de Souza Neto, Lauro Ribeiro, et al.
Publicado: (2020)

The effect of Working Alliance on drug attitude in patients with Major Depressive Disorder
por: Santarelli, G., et al.
Publicado: (2022)

Novel Insights in the Potential of Halogenated Polyketide–Peptide Molecules as Lead Compounds in Cancer Drug Discovery
por: Pellicioni, Valentina, et al.
Publicado: (2023)

Label-Free Mass Spectrometry Proteomics Reveals Different Pathways Modulated in THP-1 Cells Infected with Therapeutic Failure and Drug Resistance Leishmania infantum Clinical Isolates
por: Tagliazucchi, Lorenzo, et al.
Publicado: (2023)

Integrated Network Pharmacology Approach for Drug Combination Discovery: A Multi-Cancer Case Study
por: Federico, Antonio, et al.
Publicado: (2022)

Discovery of a Carbazole-Derived Lead Drug for Human African Trypanosomiasis
por: Thomas, Sarah M., et al.
Publicado: (2016)

Encoded Library Technologies as Integrated Lead Finding Platforms for Drug Discovery
por: Ottl, Johannes, et al.
Publicado: (2019)

Identification of natural cytochalasins as leads for neglected tropical diseases drug discovery
por: Valli, Marilia, et al.
Publicado: (2022)

Editorial: Integration of structural biology data in lead drug discovery and optimization
por: Roversi, Pietro, et al.
Publicado: (2023)

A Comprehensive Review on Steroidal Bioconjugates as Promising Leads in Drug Discovery
por: Bansal, Ranju, et al.
Publicado: (2022)

Exploring Chemical Diversity of Phorbas Sponges as a Source of Novel Lead Compounds in Drug Discovery
por: Caso, Alessia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_roteu4vkn7gv746nvsq8dq5840